Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheldon Tobe

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
CJC Open|March 16, 2026
Consensus Methodology for the Canadian Brain and Heart Clinical Practice GuidelinesZhe Li, Sheldon Tobe, Diana Sherifali, et al.
American Journal of Hypertension|December 6, 2025
The Role of Renal Denervation in the Treatment of Hypertension in Canada: A Case-Based Discussion from the Canadian Hypertension Specialists SocietyRaj S Padwal, Michael Dorsch, Sheldon Tobe, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 15, 2014
Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKDMarcel Ruzicka, Robert R Quinn, Phil McFarlane, et al.
CJC Open|September 2, 2025
Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEARTWade Thompson, Brendan Wong, Atul Sivaswamy, et al.
CMAJ Open|August 23, 2022
Trends in glucose testing among individuals without diabetes in Ontario between 2010 and 2017: a population-based cohort studyAnna Chu, Baiju R Shah, Mohammed Rashid, et al.
Canadian Journal of Kidney Health and Disease|June 16, 2015
Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney diseaseRachel M Holden, Sarah L Booth, Andrew G Day, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2005
Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKDAdeera Levin, Ognjenka Djurdjev, Christopher Thompson, et al.
Globalization and Health|March 17, 2017
Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research programMichaela A Riddell, Nancy Edwards, Simon R Thompson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 27, 2016
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL TrialKatherine R Tuttle, Lance D Dworkin, William Henrich, et al.
Global Heart|November 16, 2019
Strategic, Successful, and Sustained Synergy: The Global Alliance for Chronic Diseases Hypertension ProgramRuth Webster, Gary Parker, Stephane Heritier, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
CJC Open|March 16, 2026
Consensus Methodology for the Canadian Brain and Heart Clinical Practice GuidelinesZhe Li, Sheldon Tobe, Diana Sherifali, et al.
American Journal of Hypertension|December 6, 2025
The Role of Renal Denervation in the Treatment of Hypertension in Canada: A Case-Based Discussion from the Canadian Hypertension Specialists SocietyRaj S Padwal, Michael Dorsch, Sheldon Tobe, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 15, 2014
Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKDMarcel Ruzicka, Robert R Quinn, Phil McFarlane, et al.
CJC Open|September 2, 2025
Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEARTWade Thompson, Brendan Wong, Atul Sivaswamy, et al.
CMAJ Open|August 23, 2022
Trends in glucose testing among individuals without diabetes in Ontario between 2010 and 2017: a population-based cohort studyAnna Chu, Baiju R Shah, Mohammed Rashid, et al.
Canadian Journal of Kidney Health and Disease|June 16, 2015
Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney diseaseRachel M Holden, Sarah L Booth, Andrew G Day, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2005
Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKDAdeera Levin, Ognjenka Djurdjev, Christopher Thompson, et al.
Globalization and Health|March 17, 2017
Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research programMichaela A Riddell, Nancy Edwards, Simon R Thompson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 27, 2016
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL TrialKatherine R Tuttle, Lance D Dworkin, William Henrich, et al.
Global Heart|November 16, 2019
Strategic, Successful, and Sustained Synergy: The Global Alliance for Chronic Diseases Hypertension ProgramRuth Webster, Gary Parker, Stephane Heritier, et al.
Pageof 7